Related Experiment Video
Updated: Jun 24, 2026

07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
28.5K
Deciphering the Role of Cancer Stem Cells in Breast Cancer Brain Colonization Using a Novel Patient-Derived Model.
Stefania Faletti1, Cristina Richichi1, Daniela Osti1
1Department of Experimental Oncology, IRCCS, European Institute of Oncology (IEO), Milan, Italy.
Advanced Healthcare Materials
|March 27, 2026
Summary
Breast cancer brain metastases (BCBM) are deadly. This study identifies cancer stem-like cells (CSCs) and a metastasis-initiating cell (MIC) subpopulation as key drivers of BCBM, revealing therapeutic targets.
Area of Science:
- Oncology
- Cancer Biology
- Metastasis Research
Background:
- Brain metastases from breast cancer (BCBM) are a significant cause of mortality with limited treatment options.
- Understanding the cellular drivers of BCBM is hindered by inadequate preclinical models that lack patient tumor heterogeneity.
- The role of cancer stem-like cells (CSCs) in the development of brain metastases is not fully understood.
Purpose of the Study:
- To isolate and characterize cancer stem-like cells (CSCs) from human BCBM specimens.
- To establish clinically relevant preclinical models for studying BCBM dissemination and heterogeneity.
- To identify specific CSC subpopulations and their molecular mechanisms driving brain metastasis.
Main Methods:
- Isolation and characterization of CSCs from human BCBM specimens, assessing stem-like properties (CD44, ALDH1 expression, sphere formation, self-renewal).
- Development of intra-nipple and intra-cardiac xenograft models to study metastasis formation.
- Transcriptomic and functional analyses to identify metastasis-initiating cell (MIC) subpopulations and their interactions with the brain microenvironment.
Main Results:
- BCBM-derived CSCs possess stem-like properties and can generate patient-specific brain and bone metastases in vivo.
- A metastasis-initiating cell (MIC) subpopulation within CSCs was identified, enriched in stemness and adhesion pathways.
- MICs demonstrate enhanced brain endothelium adhesion and undergo brain-specific reprogramming, facilitating survival and progression in the brain.
Conclusions:
- CSCs and the identified MIC subpopulation are critical drivers of breast cancer brain metastasis.
- These findings establish a clinically relevant preclinical model for BCBM research.
- CSCs and MICs represent promising therapeutic targets for overcoming treatment resistance in BCBM.

